Pharmaceuticals - Union Register


List of nationally authorised medicinal products for human use


Product name: Xeomin
Active substance: Clostridium botulinum type A neurotoxin
Indication: Xeomin is indicated for the symptomatic management of blepharospasm and cervical dystonia of a predominantly rotational form (spasmodic torticollis) in adults.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/10/2007 Referral EMEA/H/A-29/856 (2007)5294 of 24/10/2007
4/02/2008 Corrigendum (2007)5294 cor of 1/02/2008